Midpoint equity value for planned UAE cell sorting entity highlights significant growth runway in high-infertility, medical-tourism hotspot Senior Strategic Advisor Nadeem Malik, former CEO of Genetics and IVF Institute and President of Fairfax Cryobank, to spearhead commercialization BANGKOK, July 06, 2026 (GLOBE NEWSWIRE) -- NewGen Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced a compelling independent valuation from a Big Four global accounting firm for its planned UAE-based cell sorting and cytometry leasing business. The Report assigns a midpoint equity value of approximately US$19 million (as of May 31, 2026

BANGKOK, June 22, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that NewGen’s total outstanding shares now stand at 10,073,535 following share issuances in connection with its strategic share purchase agreements to acquire a 10% equity interest in K25.ai. The Company’s market capitalization reached US$7,631,710 on June 18, 2026, providing a solid foundation for future growth. Management views this market capitalization as representing a substantial discount to the Company’s net asset value of approximately US$25.98 million as of December 31, 2025. The balance sheet has been further strengthened by the Company’s subsequent US$10 m

K25.ai to complete its US$10 million Pre-A at a US$100 million valuation and is now raising its Series A to accelerate product launch and regional expansion NewGen's expanded stake and exclusive Asia-Pacific agency rights deepen its strategic participation in K25.ai's next phase of growth BANGKOK, June 18, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has executed an agreement for a further US$4 million strategic investment in K25.ai. The transaction completes K25.ai's US$10 million Pre-A round at a US$100 million valuation and, upon completion and satisfaction of the ap

NewGen to repurchase all outstanding convertible notes and warrants previously held by a significant investor in move to strengthen its capital structure Settlement to eliminate potential dilution from convertible notes and warrants Company views that this will position the Company's market capitalization to be undervalued relative to net assets BANGKOK, June 16, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today announced that it has entered into a Repurchase and Forbearance Agreement (the "Settlement Agreement") with a significant investor (the "Investor"). Under the terms of the Settlement Agreement, NewGen will repurchase all outstandi

SINGAPORE, June 4, 2026 /PRNewswire/ -- K25.ai, an AI-native livestreaming and watch-to-predict prediction market platform purpose-built for Asia-Pacific, today announced that NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen") has committed an additional US$4 million strategic investment in K25.ai, bringing NewGen's total strategic investment in K25.ai to US$6 million at an implied valuation of US$100 million and further deepening the partnership between the two companies. The additional investment strengthens NewGen's strategic exposure to K25.ai and underscores growing recognition of K25.ai's positioning at the convergence of AI, livestreaming, digital assets and prediction markets. As part

NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.

NewGen executes Share Purchase Agreement to acquire an initial 2% equity interest in K25.ai, with the right to invest up to 10% in totalNewGen also executes Exclusive Agency Agreement with K25.ai, appointing NewGen as K25.ai's exclusive agency partner for selected permitted APAC markets, creating a potential asset-light commercial growth channelAccording to media reports citing Bernstein research, prediction market volumes could reach approximately US$1 trillion by 2030 as the category evolves into broader information markets across sports, crypto, politics, macroeconomic and event-driven contractsAPAC market tailwinds across mobile, digital economy, gaming, esports, live-streaming, social v

Nasdaq-listed NIVF has made an initial US$2 million strategic investment in K25.ai (with an option for up to US$10M). K25.ai co-founders will join NIVF's board to support deeper strategic alignment, as the partnership accelerates K25.ai's AI-native watch-to-predict platform and APAC expansion. K25.ai is also pursuing a potential public-market pathway, including through a strategic transaction or RTO.SINGAPORE, May 21, 2026 /PRNewswire/ -- K25.ai, an APAC-focused AI-native live streaming and watch-to-predict platform, today announced the closing of a US$100 million-valued Pre-A strategic investment round led by NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGenIVF" or "NIVF"), together with an ex

BANGKOK and SINGAPORE, May 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGenIVF" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered into a strategic investment agreement with K25.ai, an APAC-focused AI-powered watch-to-predict platform led by Mr. Andy Cheung, former Chief Operating Officer of OKX and former Chief Executive Officer of Groupon Hong Kong. K25.ai is designed to combine artificial intelligence, live-streaming content, creator communities and prediction-based engagement into a watch-to-predict consumer platform for permitted APAC markets. The strategic relationship is intended to provide NewGenIVF wi

NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today outlined several highlights of its fiscal year 2025 results and the steady progress of its continued strategic transformation. More information on NewGen's results can be found in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, (the "2025 Annual Report") which was filed with the U.S. Securities and Exchange Commission (the "SEC") in April 2026. The ful

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

3/A - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

3 - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

6-K - NewGenIvf Group Ltd (0001981662) (Filer)

RW - NewGenIvf Group Ltd (0001981662) (Filer)

Midpoint equity value for planned UAE cell sorting entity highlights significant growth runway in high-infertility, medical-tourism hotspot Senior Strategic Advisor Nadeem Malik, former CEO of Genetics and IVF Institute and President of Fairfax Cryobank, to spearhead commercialization BANGKOK, July 06, 2026 (GLOBE NEWSWIRE) -- NewGen Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced a compelling independent valuation from a Big Four global accounting firm for its planned UAE-based cell sorting and cytometry leasing business. The Report assigns a midpoint equity value of approximately US$19 million (as of May 31, 2026

NewGen's 6% Stake in K25.ai Now Valued at US$6 MillionCompany will Leverage Expertise of K25.ai's Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced it has exercised its top-up option to acquire an additional 4% equity interest in AI-native livestreaming prediction market platform K25.ai, raising its total holding to 6%. The additional US$4 million investment, which supplements an initial US$2 million investment announced in May 2026, is split evenly between cash and newly issued NewGen Class A ordinary shares.

BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group's tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong's first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF's inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026. As S

Service agreement with SAXA, Inc. appoints NewGenDigital as SAXA's worldwide tokenization agent, strengthening cooperation between the two companies ahead of proposed reverse merger Value of tokenized assets could be expanded to US$1 billion under the terms of the agreement; NewGenDigital to earn 5% commission on assets sold BANGKOK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that its subsidiary, NewGenD

Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to specific conditions. Additionally, the Company announced the appointment of Mr. Thorain Ko as Business Development Director to drive its expansion initiatives. Nasdaq Listing UpdateThe Pane

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

4 - NewGenIvf Group Ltd (0001981662) (Issuer)

SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today outlined several highlights of its fiscal year 2025 results and the steady progress of its continued strategic transformation. More information on NewGen's results can be found in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, (the "2025 Annual Report") which was filed with the U.S. Securities and Exchange Commission (the "SEC") in April 2026. The ful